MDMA logo

Pharmala Biotech Holdings Inc. Stock Price

CNSX:MDMA Community·CA$13.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

MDMA Share Price Performance

CA$0.12
-0.04 (-25.00%)
CA$0.12
-0.04 (-25.00%)
Price CA$0.12

MDMA Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Pharmala Biotech Holdings Inc. Key Details

CA$420.8k

Revenue

-CA$130.0k

Cost of Revenue

CA$550.8k

Gross Profit

CA$2.6m

Other Expenses

-CA$2.0m

Earnings

Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
-0.019
130.89%
-484.41%
0%
View Full Analysis

About MDMA

Founded
n/a
Employees
n/a
CEO
Nicholas Kadysh
WebsiteView website
pharmala.ca

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.

Recent MDMA News & Updates

Recent updates

No updates